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Foamy viruses have several qualities favorable for vector development: they are not known to cause disease; they can transduce
stationary cells; and the foamy virus receptor is expressed on a wide variety of cells. Here, we analyzed the level of virus receptor
expression on hematopoietic progenitor cells. Foamy virus binding was measured by a flow cytometric assay and was found to
be considerably reduced in hematopoietic progenitors cell lines as well as in primary CD341 cells when compared to fibroblasts.
Retroviral vectors based on murine leukemia virus (MLV) pseudotyped with a foamy virus envelope transduced hematopoietic cell
lines with a more than 10-fold lower efficiency than fibroblasts. Moreover, less than 1% of primary CD341 hematopoietic progenitor
cells were transduced with the foamy virus pseudotypes, while gene transfer efficiencies of 8–40% were achieved using
pseudotypes with amphotropic envelope or the G protein of vesicular stomatitis virus. In conclusion, the expression of functional
foamy virus receptors on hematopoietic progenitors cells was found to be insufficient to achieve high levels of gene transfer into
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INTRODUCTION
In clinical trials, the level of gene marking by retroviral
gene transfer into repopulating hematopoietic stem cells
has generally been disappointing. These low transduc-
tion rates are attributed to a lack of receptors for retro-
viral vectors derived from murine leukemia virus (MLV)
on hematopoietic progenitors (von Laer et al., 1998). In
addition, MLV-derived vectors require cell division for
efficient transduction and hematopoietic stem cells are
mostly quiescent (Lewis and Emerman, 1994). Recently,
however, transduction protocols have been improved
considerably by including fibronectin to colocalize virus
and cells and by the use of appropriate growth factors to
stimulate early progenitors (Abonour et al., 2000; Cheng
et al., 1998; Conneally et al., 1998; Donahue et al., 2000).
In addition, the use of lentiviral vectors derived from the
human immunodeficiency virus type 1 (HIV-1) allows the
transduction of nondividing stem cells (Miyoshi et al.,
1999). However, although the generation of a replication
competent retrovirus caused by several recombination
events is extremely unlikely in the most recent genera-
tion of lentiviral packaging system, safety concerns still
remain (Klimatcheva et al., 1999).
Foamy viruses (FVs) are complex retroviruses with sev-
eral qualities that are ideal for vector development and
therefore are an attractive alternative to lentiviral vectors.
1 To whom correspondence and reprint requests should be addressed
t Georg-Speyer-Haus, Paul-Ehrlich-Strasse 42-44, 60596 Frankfurt, Ger-
any. Fax: 49-69-63395297. E-mail: laer@em.uni-frankfurt.de.
139nts using current transduction protocols. © 2001 Academic Press
FV infection is less dependent on cell cycle than MLV
infection (Bieniasz et al., 1995; Roe et al., 1993; Russell and
Miller, 1996). FVs are not prevalent in humans and in con-
trast to MLV or lentiviruses have never been conclusively
associated with disease (Schweizer et al., 1995). The FV
receptor(s) is expressed on a wide range of different cell
types and species, including cells of different hematopoi-
etic lineages (Mikovits et al., 1996; von Laer et al., 1996).
Foamy virus packaging systems free of helper virus have
recently been developed (Heinkelein et al., 1998; Trobridge
and Russell, 1998; Wu and Mergia, 1999).
Hirata and co-workers found that the gene transfer
efficiency of FV vectors for CD341 hematopoietic progen-
tors compared favorably with MLV-derived vectors
Hirata et al., 1996). However, these high transduction
ates were only achieved by coculture of CD341 cells
with the FV producing cell lines, while gene transfer with
cell-free FV vector supernatant was extremely inefficient.
One possible explanation for this finding is that the
expression of FV receptor is low on primary hematopoi-
etic progenitors. We therefore analyzed the level of
foamy virus receptor on primary human hematopoietic
progenitors and hematopoietic cell lines. Our results
suggest that hematopoietic progenitors indeed lack
functional FV receptor.
RESULTS
Foamy virus binding to hematopoietic progenitorsThe density of foamy virus receptor on hematopoietic
cells was analyzed using a flow cytometric virus binding
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AER Eassay. Cells were incubated with concentrated virus su-
pernatants and bound virus was detected by antibodies
to SFV-1. The result of a typical experiment for the human
fibroblast cell line Te671 is shown in Fig. 1. Several cell
lines were analyzed in parallel (Figs. 1 and 2). To quantify
the level of virus binding, the difference in staining of
cells incubated with virus vs cells incubated with control
supernatants was determined. In each experiment, virus
binding to Te671 was also analyzed. The mean binding of
at least three independent experiments is shown in Fig.
2 and given relative to the level of binding for Te671
(5100%). All adherent cell lines showed high levels of
virus binding, while lymphoid cells had an intermediate
level. Barely detectable levels of binding (,5%) were
observed for the mouse hematopoietic stem cell line
FDC-Pmix and for primary human CD341 progenitors.
irus binding to CD341 cells increased slightly after
prestimulation with growth factors (SCF, IL-3, and Flt-3
ligand).
Inefficient gene transfer to hematopoietic cell lines by
MLV vectors pseudotyped with foamy virus envelope
glycoprotein
We then asked whether the low level of virus binding
on hematopoietic cells restricted virus entry. In a previ-
ous study, we had shown that the cell lines studied here
FIG. 1. Te671 (human fibroblast cell line), FDC-Pmix (mouse hema-
topoietic stem cell line), and CD341 cells (primary human hematopoi-
etic progenitor cells) were incubated with saturating amounts of con-
centrated SFV-1 (solid black curve) or with medium (control, shaded
curve). Bound virus was detected by a rabbit antiserum to SFV-1.
140 VON L(Fig. 2) can be transduced with similar efficiencies by an
MLV-based retroviral vector pseudotyped with the VSV Gprotein (von Laer et al., 1998). Thus, there is no consid-
erable postentry restriction for MLV-based vectors in
these cell lines. The transduction efficiency with an MLV-
based vector pseudotyped with foamy virus envelope
should therefore reflect the level of functional foamy
virus receptor on the cell surface.
Native full-length foamy virus envelope glycoproteins
only inefficiently pseudotype MLV (Lindemann et al.,
1997). However, titers between 1 and 5 3 104 can be
chieved with a chimeric envelope glycoprotein consist-
ng of an MLV cytoplasmic domain fused to the truncated
xtracellular HFV or SFV-1 envelope protein (Fig. 3A).
he titers of these foamy virus pseudotypes were deter-
ined on different cell lines. The vector genome (pSF-
GFP) contained the EGFP gene under the control of an
FFV promoter, which allows a high level of expression
n hematopoietic progenitors. The results are shown in
ig. 3B. All cell lines could be transduced with the foamy
irus pseudotype, but differed significantly in suscepti-
ility. Adherent cell lines were most susceptible, while
he mouse stem cell line FDC-Pmix, which had been
lready shown to lack functional receptor in the binding
ssay, was least susceptible. Cell lines showing inter-
ediate binding in Fig. 2 also had an intermediate sus-
eptibility. These results confirmed that expression of
oamy virus receptor on hematopoietic cells is low,
hereby restricting entry of retroviral vectors through the
oamy virus envelope glycoprotein.
ntry of foamy virus pseudotypes is restricted in
D341 hematopoietic progenitors
Integration of the MLV vector proviral DNA into the
ost genome requires mitosis, but early hematopoietic
rogenitors rarely cycle. Therefore, transduction effi-
FIG. 2. Cells were stained as shown in Fig. 1. The difference in
staining of cells (geometric mean fluorescence) incubated with virus vs
cells incubated with control supernatants was determined. In each
experiment, virus binding to Te671 was also analyzed. The mean level
of binding of at least three independent experiments is shown in
percentage of binding to Te671. Origin of cell lines: FDC-Pmix: mouse
hematopoietic stem cell; FDC-P1: mouse myeloid progenitor; TF-1:
human hematopoietic progenitor; Namalwa: human B lymphocytic;
T AL.Jurkat: human T lymphocytic; 293: human epithelial; L929: mouse fibro-
blast; Te671: human fibroblast.
. Cells were analyzed on a flow cytometer and the vector titer was calculated.
of the cell lines is given in Fig. 2.
mciency in CD341 progenitors cannot be compared di-
rectly to the transduction efficiency in proliferating fibro-
blasts (as done in Fig. 3 for the actively cycling hemato-
poietic cell lines). We therefore analyzed the transfer
efficiency with foamy virus pseudotypes in comparison to
the classical amphotropic and the VSV G pseudotypes.
For all three pseudotypes, transductions were performed
in six-well plates using 1 3 104 cells and 1 ml vector
supernatant. For the different pseudotypes tested, the
supernatants were all diluted to the same titer and the
same multiplicity of infection. Titers were determined on
Te671 cells. Although fibronectin (FN) had been shown to
considerably improve transfer efficiency for amphotropic
vectors and, to a lesser extent, of VSV G pseudotypes, no
data concerning the effect of FN on foamy virus
pseudotypes are available (Hanenberg et al., 1996;
Moritz et al., 1994; von Laer et al., 2000). We therefore
performed transductions with and without FN. The re-
sults of six experiments are shown in Table 1. CD341
progenitors were efficiently transduced with VSV G and
amphotropic pseudotypes. In contrast, the level of trans-
duction was extremely low for both the chimeric HFVenv
and the SFVenv pseudotypes and at least 50- to 100-fold
less efficient than with the classical amphotropic and
VSV G pseudotypes under equivalent conditions. Al-
though FN improved the transduction with VSV G and
amphotropic pseudotypes, FN could not improve trans-
FIG. 3. (A) Map of the C-terminus of the hybrid foamy virus Env prote
transduced with a retroviral vector expressing EGFP pseudotyped w
cytoplasmic domain of the murine leukemia virus envelope glycoprotein
The titers are given relative to the titer measured on Te671. The origin
FOAMY VIRUS RECEPTOins used for pseudotyping MLV vectors is shown. (B) Different cell lines were
ith either a chimeric HFV or a SFV envelope glycoprotein that carries the
141R ON HEMATOPOIETIC CELLSduction efficiencies of the foamy virus pseudotype to
significant levels. Also, the addition of protamine sulfateTABLE 1
Inefficient Gene Transfer to CD341 Progenitor Cells
with Foamy Virus Pseudotypes
Experiment
No. Source Pseudotype m.o.i. Fibronectin
%
Positivea
1 CB VSV G 2 3 6b no 19
VSV G 2 3 6 yes 27
HFVenv 2 3 2 no 0.1
HFVenv 2 3 2 yes 0.3
SFV-1env 2 3 2 no 0.1
SFV-1env 2 3 2 yes 0.2
2 CB VSV G 6 yes 31
HFVenv 3 yes 0.7
SFV-1env 3 yes 0.1
3 CB Amphotropic 3 yes 29
VSV G 20 no 11
VSV G 20 yes 40
HFVenv 30 no 0.1
HFVenv 30 yes 0.3
4 CB Amphotropic 10 yes 11
VSV G 10 yes 25
SFV-1 6 yes ,0.1
5 CB Amphotropic 10 yes 19
HFVenv 30 yes 0.2
6 BM Amphotropic 10 yes 8
HFVenv 30 yes 0.2
Note. CB, Cord blood; BM, Bone marrow.
a Gates were set to allow a background of 0.1% positive cells in the
ock-infected control.
b Cells were transduced twice after 2 and 3 days of prestimulation
with growth factors.
s
a
p
l
f
p
S
F
d
i
m
V
s
1
p
e
a
d
n
a
c
c
i
c
g
h
l
(
t
p
p
c
l
s
h
u
g
r
e
t
b
t
t
l
o
c
f
s
d
a
C
c
w
(
s
T
m
w
G
s
K
1
i
r
r
c
(
e
a
V
d
S
s
w
v
c
AER Ehad no influence on the transfer efficiency for the foamy
virus pseudotype (data not shown).
DISCUSSION
This study shows that entry of retroviral vectors
pseudotyped with foamy virus envelope glycoproteins is
restricted in hematopoietic progenitor cells and that this
restriction most likely reflects an insufficient expression
of functional foamy virus receptors.
Flow cytometric virus binding assays have been suc-
cessfully used to determine the level of functional virus
receptors on different cell types and have been found to
correlate well with the susceptibility to virus infection
(Crooks and Kohn, 1993). In hematopoietic progenitors,
growth factors increase binding of amphotropic retrovi-
rus as well as susceptibility to retroviral gene transfer.
Using a flow cytometric assay, binding of a fusion protein
consisting of the surface domain of the envelope glyco-
protein of SFVcpz and the Ig-G Fc fragment (Env-SU-Ig)
was found to correlate with the susceptibility to FV in-
fection of both adherent and lymphoid cells (Herchen-
roder et al., 1999). While fibroblasts and epithelial cells
howed a high level of binding and lymphocytes showed
n intermediate level, binding to some hematopoietic
rogenitor cells was barely above detection limit. The
evel of binding to lymphoid cells is most likely sufficient
or transduction, as a recent publication has shown that
rimary T lymphocytes can be efficiently transduced with
FV-1 vectors (Mergia et al., 2001). However, the lack of
V binding to hematopoietic progenitors is a strong in-
ication for an insufficient expression of FV receptors.
Efficient transduction of MLV-based retroviral vectors
n primary hematopoietic progenitor cells under opti-
ized transduction conditions was achieved with the
SV G and amphotropic pseudotypes as has been de-
cribed previously (Cheng et al., 1998; Coneally et al.,
998), but not with FV pseudotypes. This observation
rovides additional evidence that transduction via the FV
nvelope as well as infection with FV is indeed restricted
t the level of virus entry.
Our study with FVenv-pseudotyped MLV vector pre-
icts that transduction with FV vectors containing a FV
ucleocapsid will also be inefficient. This prediction is in
greement with the results of a previous study by Yu and
o-workers, where replication of HFV in hematopoietic
ell lines was studied (Yu et al., 1996). Interestingly,
nfection with cell-free virus was not successful and
ocultivation was required to infect hematopoietic pro-
enitor cells. Similar results were obtained for primary
uman CD341 progenitors, where efficient transduction
evels were achieved only by a cocultivation protocol
Hirata et al., 1996). Preliminary results in our lab confirm
hese observations (D. von Laer and M. Heinkelein, un-
142 VON Lublished observations). Unfortunately, safety concerns
reclude cocultivation with FV vector producer cells for
v
ulinical applications as long as stable packaging cell
ines for this vector system are not available.
However, several additional aspects should be con-
idered. The protocol used by Hirata et al. (1996) may not
ave been optimal for the transduction with FV vectors
sing cell-free supernatants, e.g., the absence of FN,
rowth factor prestimulation, etc. Furthermore, for two
easons, entry of MLV(FV) pseudotypes may be less
fficient than entry of genuine FV particles. The concen-
ration of FV envelope glycoprotein on FV vectors could
e higher than of the chimeric FV-MLVenv on MLV par-
icles due to a more efficient assembly of particles with
he genuine components. Envelope incorporation most
ikely involves specific interaction of the cytoplasmic tail
f the FV transmembrane glycoprotein with the nucleo-
apsid protein. This interaction could also be essential
or efficient entry via the foamy virus receptor. Further
tudies are required to determine whether efficient trans-
uction of hematopoietic progenitor cells for gene ther-
py with cell-free FV vectors can be achieved.
MATERIALS AND METHODS
ell lines, viruses, and vectors
The human kidney cell line 293, the human fibroblast
ell line Te671, and the mouse fibroblast cell line L-929
ere cultured in Dulbecco’s minimal essential medium
GIBCO, Paisley, U.K.) supplemented with 10% fetal calf
erum. The human hematopoietic progenitor cell line
F-1 (Kitamura et al., 1989) was maintained in Iscove’s
odified Dulbecco’s medium (GIBCO) supplemented
ith 10% fetal calf serum and IL-3 (Roche Diagnostics
mbH, Mannheim, Germany) at concentrations neces-
ary for maximum growth. The human progenitor cell line
562, the human B-cell line Namalwa (Nyormoi et al.,
973), and the human T-cell line Jurkat were maintained
n RPMI (GIBCO) supplemented with 10% fetal calf se-
um. Cell lines were purchased from ATCC.
SFV-1 is the prototype macaque foamy virus isolate
ecovered from Macaca cyclopsis and was molecularly
haracterized by Mergia et al. (1990) and Kupiec et al.
1991). pSF-EGFP was cloned by inserting the gene for
nhanced green fluorescence protein (EGFP) into pSF11
s described (Wahlers et al., 2001).
irus binding assay
The virus binding assay was adapted from a method
escribed previously for MLV (Crooks and Kohn, 1993).
FV-1 was concentrated by ultracentrifugation of virus
upernatants in a Beckmann SW28 for 2 h at 25,000 rpm
ithout a sucrose cushion. Ultracentrifugation increased
irus concentration so that saturation of cell binding
ould be achieved (data not shown). The concentrated
T AL.irus was frozen in aliquots and titrated on Te671 cells
sing the binding assay described here. Virus concen-
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R ONtrations twofold over saturation levels were used in all
assays. Cells (2 3 105 per sample) were harvested by
brief trypsinization (only necessary for adherent cells),
rinsed with serum containing medium, and resuspended
in 300 ml concentrated SFV-1. Preceding experiments
ad shown that brief trypsinization has no influence on
he binding efficiency of FV. After an incubation of 45 min
t 4°C, cells were washed three times with 2 ml ice-cold
hosphate-buffered saline (PBS) with 5% FCS. Cells were
esuspended in 50 ml rabbit serum (1:30) raised against
FV-1 and incubated on ice for 30 min. They were then
ashed again three times, resuspended in 50 ml of the
secondary antibody (biotinylated goat anti-rabbit anti-
body, Pharmingen, Hamburg, Germany), and incubated
on ice for another 30 min. After the next washing, cells
were incubated with 50 ml streptavidin–phycoerythrin on
ce for 10 min, washed again three times, and finally fixed
n 500 ml PBS with 1% paraformaldehyde. Samples were
nalyzed for fluorescence intensity on a flow cytometer
FACScalibur, Becton–Dickinson, Heidelberg, Germany).
oamy virus pseudotypes
The expression construct for chimeric envelope pro-
ein containing an unprocessed MLV cytoplasmic do-
ain fused to the truncated human foamy virus (HFV)
nvelope HFVD2MuLV was described previously (Linde-
ann et al., 1997). A similar construct for the simian
foamy virus type 1 (SFV-1) envelope gene was cloned.
The extracellular domain of the SFV-1 env was amplified
by polymerase chain reaction (PCR) introducing an NheI
site at the position corresponding to an NheI site in the
HFV env (SFV-1env59: acagcttatcaggataatggc and SFV-1/
39NheI: ttgctgcagctagctgtttcagccagtcagg). The cleaved
amplimer was introduced into the EcoRV site of pBlue-
script (pBS-SFVD). The NheI/XhoI fragment from
HFVD2MuLV was then introduced into pBS-SFVD. The
complete orf was then transferred into EcoRI of pSBC-2
(Dirks et al., 1993).
The MLV-based retroviral vector pseudotyped with chi-
meric foamy virus envelopes was produced by transient
cotransfection of 293 gp cells with pSF-EGFP and the
expression plasmid for the chimeric foamy virus enve-
lope (von Laer et al., 1998). For several transductions,
vector supernatants were concentrated by ultracentrifu-
gation in a Beckmann SW28 rotor for 2 h at 25,000 rpm at
4°C without significant loss of infectivity.
Purification of CD341 cells
After informed consent, CD341 cells were isolated
rom bone marrow, leukapheresis, and cord blood sam-
les. Mononuclear cells were isolated by Ficoll (Bio-
hrom, Berlin, Germany) gradient centrifugation and the
FOAMY VIRUS RECEPTOD341 population was enriched to over 98% purity, as
determined by FACS analysis, by two sequential columnsusing the MACS progenitor cell isolation kit (Miltenyi
Biotec, Bergisch-Gladbach, Germany).
Transduction of CD341 Cells
Purified hematopoietic progenitor cells (1–4 3 104/ml)
were prestimulated in BIT medium (Cellsystems Biotech-
nologie, St. Katharinen, Germany) with stem cell factor
(rhu SCF, 100 ng/ml, Roche Diagnostics), Flt-3 ligand (rhu
FL, 100 ng/ml, Pepro Tech/Tebu, Frankfurt am Main,
Germany), and interleukin-3 (rhu IL-3, 20 ng/ml, Roche
Diagnostics) for 44 h. Cells were then pelleted and re-
suspended at a density of 1 3 104/ml in vector superna-
ants supplemented with growth factors (FL, SCF, IL-3)
nd 8 mg/ml protamine sulfate and incubated for 1 h at
7°C. Some transductions were done in fibronectin-
oated six-well plates (Falcon/Becton–Dickinson, Bed-
ord, MA). Cells were then diluted with growth-factor
upplemented BIT medium, cultured for another 48–72 h,
nd then analyzed on a FACScalibur (Becton–Dickinson).
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